Colgate-Palmolive (CL)
Colgate-Palmolive (CL) Stock Price, Analysis & Data
| Bid | 92.31 |
| Market Cap | 73.52B |
| Revenue (ttm) | 21.05B |
| Net Income (ttm) | 2.04B |
| Beta | 0.33 |
| EPS (ttm) | 2.54 |
| PE Ratio (ttm) | 36.31 |
| Forward PE | 22.49 |
| P/B (ttm) | 311.55 |
| P/S (ttm) | 3.49 |
| Earnings Date | Oct 30, 2026 |
| Ask | 92.4 |
| Volume | 421,216 |
| Avg. Volume (20D) | 5,096,482 |
| Open | 91.32 |
| Previous Close | 92.31 |
| Day's Range | 91.30 - 92.60 |
| 52-Week Range | 74.55 - 99.33 |
| Analyst | Buy |
| Price Target | 100.5 (8.98%) |
| Dividends | $2.12 (2.28%) |
| Ex-Dividend Date | Jul 20, 2026 |
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents...
Financial Performance
In 2025, Colgate-Palmolive's revenue was 20.38B, an increase of 1.4% compared to the previous year's 20.1B. Earnings were 2.13B, a decrease of -26.2%.
Financial StatementsAnalyst Forecast
According to 20 analyst ratings, the average rating for CL stock is "Buy". The 12-month stock price forecast is 100.5, which is upside of 8.98% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade